R. Eric Davis

10.3k total citations
4 papers, 326 citations indexed

About

R. Eric Davis is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, R. Eric Davis has authored 4 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in R. Eric Davis's work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). R. Eric Davis is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). R. Eric Davis collaborates with scholars based in United States. R. Eric Davis's co-authors include Lloyd T. Lam, Oxana K. Pickeral, Jena M. Giltnane, Edward A. Sausville, Melinda G. Hollingshead, Judy A. Mikovits, Anne Monks, A Peng, Elaine M. Hurt and Larry M. Wahl and has published in prestigious journals such as Blood, Genome biology and Hematological Oncology.

In The Last Decade

R. Eric Davis

4 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Eric Davis United States 2 229 138 45 37 35 4 326
Jeffrey Hannah United States 7 341 1.5× 143 1.0× 20 0.4× 13 0.4× 25 0.7× 7 442
Christian A. Bösken Germany 6 597 2.6× 256 1.9× 28 0.6× 20 0.5× 79 2.3× 6 706
Caila Ryan United States 9 385 1.7× 67 0.5× 13 0.3× 30 0.8× 26 0.7× 9 456
Georgina P. Sava United Kingdom 7 222 1.0× 191 1.4× 31 0.7× 53 1.4× 129 3.7× 8 369
Reed Jc United States 8 312 1.4× 149 1.1× 52 1.2× 139 3.8× 25 0.7× 12 483
Jenni Nikkilä Finland 10 337 1.5× 121 0.9× 66 1.5× 10 0.3× 14 0.4× 11 433
Zeping Luo United States 8 421 1.8× 209 1.5× 25 0.6× 16 0.4× 82 2.3× 8 581
Stefan Rebhandl Austria 7 135 0.6× 121 0.9× 60 1.3× 88 2.4× 14 0.4× 8 319
Poorval Joshi United States 6 219 1.0× 134 1.0× 22 0.5× 17 0.5× 33 0.9× 9 301
Harish Potu United States 10 364 1.6× 201 1.5× 14 0.3× 15 0.4× 13 0.4× 17 439

Countries citing papers authored by R. Eric Davis

Since Specialization
Citations

This map shows the geographic impact of R. Eric Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Eric Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Eric Davis more than expected).

Fields of papers citing papers by R. Eric Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Eric Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Eric Davis. The network helps show where R. Eric Davis may publish in the future.

Co-authorship network of co-authors of R. Eric Davis

This figure shows the co-authorship network connecting the top 25 collaborators of R. Eric Davis. A scholar is included among the top collaborators of R. Eric Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Eric Davis. R. Eric Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Westin, Jason R., Nathan Fowler, Michelle A. Fanale, et al.. (2017). HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY. Hematological Oncology. 35(S2). 120–121. 9 indexed citations
2.
Westin, Jan, Luis Fayad, Francesco Turturro, et al.. (2017). RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE AND COMBINED WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA. Hematological Oncology. 35(S2). 190–191. 1 indexed citations
3.
4.
Lam, Lloyd T., Oxana K. Pickeral, A Peng, et al.. (2001). Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome biology. 2(10). RESEARCH0041–RESEARCH0041. 315 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Hannah Breakdown of academic impact, for papers by Christian A. Bösken Breakdown of academic impact, for papers by Caila Ryan Breakdown of academic impact, for papers by Georgina P. Sava Breakdown of academic impact, for papers by Reed Jc Breakdown of academic impact, for papers by Jenni Nikkilä Breakdown of academic impact, for papers by Zeping Luo Breakdown of academic impact, for papers by Stefan Rebhandl Breakdown of academic impact, for papers by Poorval Joshi Breakdown of academic impact, for papers by Harish Potu
Rankless by CCL
2026